Diannexin Decreases Inflammatory Cell Infiltration Into the Islet Graft, Reduces β-Cell Apoptosis, and Improves Early Graft Function
- 15 October 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 90 (7), 709-716
- https://doi.org/10.1097/tp.0b013e3181ed55d8
Abstract
Background. A major unmet challenge is to reduce the islet mass needed for insulin independence in type 1 diabetic recipients after islet transplantation. The recombinant homodimer of human annexin V, diannexin, has completed a Phase II Clinical Trial in Kidney Transplantation (NCT00615966). Methods. We developed a marginal islet mass transplantation model (10–12 islets per gram of recipient body weight) and investigated whether diannexin prevents β-cell apoptosis and improves islet graft function. Diannexin was administered to islet cell donors shortly before pancreas harvest, added to isolation reagents, and infused into recipients at the time of transplantation and repeated daily until day 4. Results. In the syngeneic marginal islet mass transplantation model, the median time needed to achieve normoglycemia was reduced from 17.0 days among untreated controls to 3.5 days among diannexin-treated recipients (P=0.004). Histologic analysis of islet grafts harvested on day 3 posttransplantation revealed decreased macrophage (44.7%±9.8% vs. 19.2%±3.2%, P=0.007) and T-cell infiltration (25.9%±5.5% vs. 9.1%±1.1%, P=0.004), and a lower rate of islet cell apoptosis (20.5%±2.8% vs. 7.6%±2.3%, P=0.01) with diannexin treatment. Expression profiling of the islet grafts showed significantly lower levels of mRNA for the proapoptotic molecule Bid, but higher levels of interleukin-6, interferon-γ, and immunosuppressive cytokine interleukin-10. Conclusions. Our findings demonstrate that diannexin improves the early function of marginal mass islet grafts, and its effects are associated with reductions in inflammatory cell infiltration and β-cell death by apoptosis after islet transplantation.Keywords
This publication has 32 references indexed in Scilit:
- Current Advances and Travails in Islet TransplantationDiabetes, 2009
- Revascularization and remodelling of pancreatic islets grafted under the kidney capsuleJournal of Anatomy, 2007
- Mitochondrial Targeting with Antioxidant Peptide SS-31 Prevents Mitochondrial Depolarization, Reduces Islet Cell Apoptosis, Increases Islet Cell Yield, and Improves Posttransplantation FunctionJournal of the American Society of Nephrology, 2007
- International Trial of the Edmonton Protocol for Islet TransplantationNew England Journal of Medicine, 2006
- Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic isletsClinical and Experimental Immunology, 2006
- Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic graftsJournal of Leukocyte Biology, 2005
- Intracellular Stress Signaling Pathways Activated During Human Islet Preparation and Following Acute Cytokine ExposureDiabetes, 2004
- Response of Human Islets to Isolation Stress and the Effect of Antioxidant TreatmentDiabetes, 2004
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenNew England Journal of Medicine, 2000
- CHRONICALLY DECREASED OXYGEN TENSION IN RAT PANCREATIC ISLETS TRANSPLANTED UNDER THE KIDNEY CAPSULE1Transplantation, 2000